Lioton

Heparin Sodium, the active ingredient in Lioton, is an anticoagulant presented as a cutaneous preparation for topical use. It works by inhibiting clot formation and is employed in patients at risk of thrombosis or requiring localized anticoagulation.

GNH USA supplies Lioton as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. Customers benefit from consistent product availability and regulatory compliance support.

Heparin Sodium is used as an anticoagulant to prevent and treat clot‑related conditions. - Deep vein thrombosis (DVT): helps prevent clot formation in the deep veins of the legs. - Pulmonary embolism (PE): reduces the risk of embolic events in the pulmonary arteries. - Superficial thrombophlebitis: alleviates clot development in superficial veins. - Hemodialysis circuit anticoagulation: maintains patency of extracorporeal circuits during dialysis. - Surgical site prophylaxis: minimizes postoperative clot formation at incision sites.

Heparin Sodium applied topically may be associated with several adverse reactions, ranging from mild to serious.

Common Side Effects: - Localized skin irritation: redness, itching, or mild rash at the application site. - Minor bruising: small areas of discoloration due to superficial bleeding. - Dryness or peeling: mild desquamation of the skin where the product is used.

Serious or Rare Side Effects: - Severe allergic reaction: hives, swelling, or anaphylaxis requiring immediate medical attention. - Significant bleeding: unexpected hemorrhage at or beyond the application area. - Heparin‑induced thrombocytopenia (HIT): a rare immune-mediated drop in platelet count.

When using Lioton, consider the following precautions to ensure safe and effective application. - Contraindication: avoid use in patients with known hypersensitivity to heparin or its excipients. - Bleeding risk: do not apply on open wounds or areas with active bleeding. - Monitoring: assess for signs of excessive bruising or unexpected bleeding during therapy. - Pregnancy and lactation: use only if the potential benefit justifies the potential risk; consult a healthcare professional. - Interaction with other anticoagulants: avoid concurrent use of additional topical or systemic anticoagulants unless directed by a clinician. - Store below 25°C: keep in the original packaging, protect from moisture and light.

Heparin Sodium can interact with other medications, influencing its anticoagulant effect.

Major Interactions (Avoid): - Concurrent systemic anticoagulants (e.g., warfarin, direct oral anticoagulants): may cause uncontrolled bleeding. - Antiplatelet agents (e.g., aspirin, clopidogrel): increase risk of hemorrhage.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may enhance bleeding tendency. - Certain antibiotics (e.g., quinolones): can potentiate anticoagulant activity. - Herbal supplements (e.g., ginkgo, garlic): may modestly increase bleeding risk.